View Older Stories View More Recent Stories
-
Surgical Care (SCAI) Commence 7M Common Secondary Offering
-
Surgical Care Affiliates, Inc. Announces Launch of Secondary Public Offering of Common Stock
-
ZS Pharma (ZSPH) Announces 3.3M Common Stock Offering
-
ZS Pharma Announces Proposed Public Offering of Common Stock
-
ZS Pharma Announces Proposed Public Offering of Common Stock
-
J.H. Whitney Completes Acquisition of PSA Healthcare
-
Notable Analyst Rating Changes 3/23: (SPLS) (ELY) (NMM) Upgraded; (NVDA) (CCL) (SHW) Downgraded
-
BMO Capital Starts Microsemi Corporation (MSCC) at Outperform
-
Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital Amid Data
-
BMO Capital Downgrades PrivateBancorp, Inc. (PVTB) to Market Perform
-
Building a Liqudity Safety Net for Public Companies and Investment Products in Canada
-
Building a Liquidity Safety Net for Public Companies and Investment Products in Canada
-
China, Belaruskali Potash Agreement Disappoints Bulls, Says BMO (POT) (AGU) (MOS) (IPI)
-
Amgen (AMGN) Abstracts Appear to Support Methods of Boosting T-VEC Effectiveness - BMO
-
BMO Capital Weighs in on OncoMed Pharmaceuticals (OMED) Following Abstracts at AACR
-
Coxe Global Agribusiness Income Fund Announces Quarterly Cash Distribution
-
First Trust Global DividendSeeker Fund Announces Monthly Cash Distribution
-
PineBridge Investment Grade Preferred Securities Fund Announces Monthly Cash Distribution
-
Star Portfolio Corp. Announces Monthly Distribution for Star Yield Managers Class
-
U.S. Housing Recovery Fund Announces Monthly Cash Distribution
-
DoubleLine Income Solutions Trust Announces Monthly Cash Distribution
-
BMO Capital Weighs in on Tesaro (TSRO) Following Abstracts at AACR
-
BMO Capital Weighs in on ARIAD Pharmaceuticals (ARIA) Following Abstracts at AACR
-
Actavis (ACT) PT Raised to $373 at BMO Capital
-
Five Prime Therapeutics (FPRX) PT Raised to $31 at BMO Capital
-
BMO Capital Questions attractiveness Energizer (ENR) Batteries and Personal Care Businesses; PT to $137
-
Regulus Therapeutics (RGLS) Bullish Stance Reiterated at BMO Capital Following EASL Abstract for RG-101
-
Tetraphase Pharma (TTPH) Closes 4.95M Common Offering for Proceeds of $173.1M
-
Tetraphase Pharmaceuticals Announces Closing of Public Offering of Common Stock
-
Notable Mergers and Acquisitions 3/16: (VRX)/(SLXP) (LTM) (KKR)/(GE) (BX) (SHLM)
-
Leonard Green, TPG to Acquire Life Time Fitness (LTM) in $4B+ Deal
-
Life Time Fitness Enters Into Definitive Agreement to Be Acquired by Affiliates of Leonard Green & Partners and TPG
-
Prospects Encouraging for $870 Billion U.S. Food and Beverage Industry: BMO Economics
-
Media Advisory: BMO Capital Markets Group Head Darryl White to Speak at the National Bank Financial 2015 Canadian Financial Services Conference
-
Tetraphase Pharma (TTPH) Prices Larger 4.3M Common Offering at $35/Share
-
Chesswood Group Limited Announces Closing of $32 Million Public Offering and Concurrent $6 Million Private Placement
-
Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Unlikely Valeant (VRX) Will Lose Salix (SLXP) Deal - BMO Capital
-
TIM Group Announces Top Performing Brokerage Firms and Salespeople in Europe and North America
-
Mylan (MYL) Off Highs as Rumors Questioned
-
BMO Capital Downgrades Prosperity Bancshares (PB) to Market Perform
-
Essex Property Trust Prices $500 Million Senior Unsecured Notes Due April 1, 2025
-
Manulife completes Subordinated Debenture offering
-
Apple (AAPL) Watch Higher Price Could Suggest Lower Units But Better Margin - BMO Capital
-
Columbia Property Trust Announces Pricing of $350 million 4.150% Senior Notes due 2025
-
Tetraphase Pharma (TTPH) Announces 3.5M Common Offering
-
Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option by Underwriters
-
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option by Underwriters
-
Dividend Select 15 Corp. Completes Overnight Offering of $17,595,000


